We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$813M
AUM Growth
+$43.5M
Cap. Flow
-$1.72M
Cap. Flow %
-0.21%
Top 10 Hldgs %
20.71%
Holding
251
New
10
Increased
63
Reduced
107
Closed
7

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$2.9M
2
AL
Air Lease Corp
AL
+$2.05M
3
IQV icon
IQVIA
IQV
+$1.92M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.89M
5
GE icon
GE Aerospace
GE
+$1.74M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.64M
2
MIDD icon
Middleby
MIDD
+$2.44M
3
GILD icon
Gilead Sciences
GILD
+$1.58M
4
ROK icon
Rockwell Automation
ROK
+$1.34M
5
AAPL icon
Apple
AAPL
+$1.04M

Sector Composition

Rank Sector Weight
1 Healthcare 17.01%
2 Industrials 14.02%
3 Technology 13.29%
4 Consumer Staples 10.45%
5 Financials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.97T
$23M 2.83%
640,860
-31,712
-5% -$1.04M
JNJ icon
2
Johnson & Johnson
JNJ
$640B
$20.3M 2.5%
163,057
-4,873
-3% -$582K
SPY icon
3
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$19.6M 2.4%
82,949
+15
+0% +$3.48K
CELG
4
DELISTED
Celgene Corp
CELG
$17M 2.08%
136,279
-7,561
-5% -$905K
UNP icon
5
Union Pacific
UNP
$174B
$15.7M 1.93%
148,280
-1,583
-1% -$169K
XOM icon
6
ExxonMobil
XOM
$650B
$15.6M 1.92%
190,566
-2,970
-2% -$248K
ANSS
7
DELISTED
Ansys
ANSS
$14.9M 1.83%
139,529
-3,622
-3% -$363K
AMT icon
8
American Tower
AMT
$83.5B
$14.7M 1.8%
120,787
-2,155
-2% -$237K
ECL icon
9
Ecolab
ECL
$79.8B
$13.9M 1.71%
110,693
-5,233
-5% -$640K
MDY icon
10
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
$13.8M 1.7%
44,242
+682
+2% +$212K
VWO icon
11
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$13.7M 1.69%
345,773
-7,463
-2% -$288K
MRSH
12
Marsh
MRSH
$94.3B
$13.4M 1.65%
181,412
-425
-0.2% -$30.4K
GE icon
13
GE Aerospace
GE
$364B
$12.7M 1.56%
88,735
+12,014
+16% +$1.74M
ROK icon
14
Rockwell Automation
ROK
$51.1B
$12.3M 1.51%
79,111
-8,973
-10% -$1.34M
PG icon
15
Procter & Gamble
PG
$340B
$12.3M 1.51%
136,366
-2,064
-1% -$183K
IJR icon
16
iShares Core S&P Small-Cap ETF
IJR
$109B
$11.9M 1.47%
172,584
+2,806
+2% +$194K
GIS icon
17
General Mills
GIS
$20.2B
$11.8M 1.45%
200,403
-354
-0.2% -$21.6K
MIDD icon
18
Middleby
MIDD
$6.01B
$11.7M 1.44%
85,887
-17,950
-17% -$2.44M
FRC
19
DELISTED
First Republic Bank
FRC
$11.6M 1.43%
123,922
+652
+0.5% +$61.4K
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.1T
$11.3M 1.39%
67,676
-482
-0.7% -$80.6K
ORCL icon
21
Oracle
ORCL
$339B
$10.8M 1.33%
242,139
-2,150
-0.9% -$89.5K
SLB icon
22
SLB Ltd
SLB
$72.7B
$10.3M 1.27%
132,467
+620
+0.5% +$50.7K
NKE icon
23
Nike
NKE
$64.1B
$9.73M 1.2%
174,684
+8,530
+5% +$471K
SRCL
24
DELISTED
Stericycle Inc
SRCL
$9.2M 1.13%
110,941
-3,720
-3% -$299K
PEP icon
25
PepsiCo
PEP
$196B
$8.92M 1.1%
79,770
-350
-0.4% -$37.6K
1
2 3 4 5

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
JFGLC
Johnson Financial Group LLC (Colorado) Denver, Colorado $1.5B AUM 16.09% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return

Boston Family Office's Q1 2017 Portfolio in Review

As of Q1 2017, Boston Family Office held 251 positions worth $813M, up 5.6% from $770M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q1 2017 filing shows 10 new, 63 increased, 107 reduced and 7 closed positions. Its largest new stake was Teradyne: 22,100 shares worth $687K. The largest sale was Teva Pharmaceuticals, an estimated $2.64M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

  • Boston Family Office's largest Q1 2017 buy was Teradyne: 22,100 shares worth $687K.
  • Boston Family Office added most to Automatic Data Processing in Q1 2017, an estimated $2.9M increase.
  • Boston Family Office's biggest Q1 2017 reduction was Middleby, cutting an estimated $2.44M.
  • Boston Family Office fully exited Teva Pharmaceuticals in Q1 2017, selling an estimated $2.64M.
  • Boston Family Office's ten largest holdings make up 21% of its $813M portfolio in Q1 2017.
  • Boston Family Office opened 10 new positions and closed 7 in Q1 2017.
  • Boston Family Office's portfolio value rose 5.6% quarter-over-quarter to $813M.

Based on Boston Family Office's 13F filing for Q1 2017, filed 5 May 2017.